PATENT CLAIM ANALYSIS

Application Number: 15895386
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["530", "387900"]

Abstract:
The present invention relates to antibodies targeting the membrane bound IgM (mIgM) of the B-cell receptor complex found in B-cell lymphomas and leukemias and uses thereof. Another aspect of the present invention is the use of anti-B-Cell mIgM antibodies in the treatment of Be-cell malignancies, including B-cell lymphomas and leukemias.

Claim (Index 48):
The method of  claim 47 , wherein the heavy chain variable region (VH) of the monoclonal antibody comprises:\n (a) a heavy chain variable region CDR1 comprising the amino acid sequence of SEQ ID NO: 5; (b) a heavy chain variable region CDR2 comprising the amino acid sequence of SEQ ID NO: 6; (c) a heavy chain variable region CDR3 comprising the amino acid sequence of SEQ ID NO: 7; and wherein the light chain variable region (LH) of the monoclonal antibody comprises: (d) a light chain variable region CDR1 comprising the amino acid sequence of SEQ ID NO: 8; (e) a light chain variable region CDR2 comprising the amino acid sequence of SEQ ID NO: 9; and (f) a light chain variable region CDR3 comprising the amino acid sequence of SEQ ID NO: 10.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.52778
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15101658', '13612070', '14295579', '10846981', '13198263']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6737225770137443
- 35 USC 102 Novelty (BERT): 0.6412515127010894
- Combined Prediction Score: 0.6704754705824788
- Mean Citation Score: 391.229066
- Max Citation Score: 726.9009
- Similarity Product: 556.3920833118439

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test